Skip to main navigation Skip to search Skip to main content

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

  • Brian Godman*
  • , Magdalene Wladysiuk
  • , Stuart McTaggart
  • , Amanj Kurdi
  • , Eleonora Allocati
  • , Mihajlo Jakovljevic
  • , Francis Kalemeera
  • , Iris Hoxha
  • , Anna Nachtnebel
  • , Robert Sauermann
  • , Manfred Hinteregger
  • , Vanda Marković-Peković
  • , Biljana Tubic
  • , Guenka Petrova
  • , Konstantin Tachkov
  • , Juraj Slabý
  • , Radka Nejezchlebova
  • , Iva Selke Krulichová
  • , Ott Laius
  • , Gisbert Selke
    • Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Bjorn Wettermark
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences